These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 12944233

  • 1. Regulation of cellular therapies: the Australian perspective.
    Wall DM, Prince HM.
    Cytotherapy; 2003; 5(4):284-8. PubMed ID: 12944233
    [Abstract] [Full Text] [Related]

  • 2. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
    Warkentin PI, Foundation for the Accreditation of Cellular Therapy.
    Cytotherapy; 2003; 5(4):299-305. PubMed ID: 12944235
    [Abstract] [Full Text] [Related]

  • 3. Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products.
    Wright C, Velickovic Z, Brown R, Larsen S, Macpherson JL, Gibson J, Rasko JE.
    Pathology; 2014 Apr; 46(3):177-83. PubMed ID: 24614714
    [Abstract] [Full Text] [Related]

  • 4. Current regulatory issues in cell and tissue therapy.
    Burger SR.
    Cytotherapy; 2003 Apr; 5(4):289-98. PubMed ID: 12944234
    [Abstract] [Full Text] [Related]

  • 5. Regulatory aspects of cellular therapy product in Europe: JACIE accreditation in a processing facility.
    Caunday O, Bensoussan D, Decot V, Bordigoni P, Stoltz JF.
    Biomed Mater Eng; 2009 Apr; 19(4-5):373-9. PubMed ID: 20042804
    [Abstract] [Full Text] [Related]

  • 6. JACIE accreditation in Europe moves ahead.
    Kvalheim G, Gratwohl A, Urbano-Ispizua A, JACIE national representatives.
    Cytotherapy; 2003 Apr; 5(4):306-8. PubMed ID: 12944236
    [No Abstract] [Full Text] [Related]

  • 7. Will regulation be the death of cell therapy in the United States?
    Gastineau DA.
    Bone Marrow Transplant; 2004 Apr; 33(8):777-80. PubMed ID: 14968138
    [Abstract] [Full Text] [Related]

  • 8. [Umbilical cord blood as a source of stem cells].
    Bojanić I, Golubić Cepulić B.
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [Abstract] [Full Text] [Related]

  • 9. A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.
    Serke S, Johnsen HE.
    Bone Marrow Transplant; 2001 Mar; 27(5):463-70. PubMed ID: 11313679
    [Abstract] [Full Text] [Related]

  • 10. [Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics].
    Maekawa T.
    Rinsho Byori; 2004 May; 52(5):430-4. PubMed ID: 15206130
    [Abstract] [Full Text] [Related]

  • 11. Professional self-regulation and guidelines in assisted reproduction.
    Chalmers D.
    J Law Med; 2002 May; 9(4):414-28. PubMed ID: 12194473
    [Abstract] [Full Text] [Related]

  • 12. The role of the Therapeutic Goods Administration and the Medicine and Medical Devices Safety Authority in evaluating complementary and alternative medicines in Australia and New Zealand.
    Ghosh D, Skinner M, Ferguson LR.
    Toxicology; 2006 Apr 03; 221(1):88-94. PubMed ID: 16481089
    [Abstract] [Full Text] [Related]

  • 13. [New Croatian legislation on tissue banking].
    Busić M.
    Acta Med Croatica; 2007 Dec 03; 61(5):445-7. PubMed ID: 18350803
    [Abstract] [Full Text] [Related]

  • 14. Regulation of cellular therapy in Australia.
    Trickett AE, Wall DM.
    Pathology; 2011 Oct 03; 43(6):627-34. PubMed ID: 21897330
    [Abstract] [Full Text] [Related]

  • 15. The Pathology Laboratory Act 2007 explained.
    Looi LM.
    Malays J Pathol; 2008 Jun 03; 30(1):1-10. PubMed ID: 19108405
    [Abstract] [Full Text] [Related]

  • 16. The harmonization of the regulation of blood products: a European perspective.
    Seitz R, Heiden M, Nübling CM, Unger G, Löwer J.
    Vox Sang; 2008 May 03; 94(4):267-76. PubMed ID: 18179678
    [Abstract] [Full Text] [Related]

  • 17. Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy.
    Lombardini L, Bosi A, Grosz S, Pamphilon D, Fehily D, Mareri M, Carella C, Pia Mariani M, Pupella S, Grazzini G, Costa AN.
    Vox Sang; 2013 Aug 03; 105(2):174-6. PubMed ID: 23398286
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
    Fraser GA, Walker II, Canadian Blood and Marrow Transplant Group.
    Biol Blood Marrow Transplant; 2004 May 03; 10(5):287-97. PubMed ID: 15111928
    [Abstract] [Full Text] [Related]

  • 19. Regulatory issues in cellular therapies.
    Sharp JG.
    Cytotherapy; 2003 May 03; 5(4):277-8. PubMed ID: 12944231
    [No Abstract] [Full Text] [Related]

  • 20. ISBT 128 implementation plan for cellular therapy products.
    Ashford P, Distler P, Gee A, Lankester A, Larsson S, Feller I, Loper K, Pamphilon D, Poston L, Rabe F, Slaper-Cortenbach I, Szczepiorkowski Z, Warkentin P, International Cellular Therapy Coding and Labeling Advisory Group.
    J Clin Apher; 2007 May 03; 22(5):258-64. PubMed ID: 17823946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.